| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_fdaa64756184e715af6cb25ebc318917
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_0d0446a5bd77c7da68216fc2e3f05d48 |
| classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-00 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K14-57563
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-16
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K19-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-28
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K7-06 |
| classificationIPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-00 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K14-47
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K14-575
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P25-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P25-28
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K14-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-22 |
| filingDate |
1994-03-08-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_758df2ceffc95df8215c82c2a8f52783
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_27a8566e46ca6693232e8348ea531569 |
| publicationDate |
1994-10-19-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
EP-0620008-A1 |
| titleOfInvention |
Use of vip, analogues and fragments thereof for the treatment of neurodegenerative diseases |
| abstract |
Use of a peptide selected from the group consisting of:n (i) vasoactive intestinal peptide (VIP); (ii) analogues of vasoactive intestinal peptide (VIP) in which one or more amino acids has been replaced, added or deleted without substantially altering the biological properties of the parent peptide (iii) a conjugate being a peptide according to either of (i) and (ii) coupled to a lipophilic moiety; (iv) a physiologically active fragment of (i), (ii) and (iii); and (v) a functional derivative of any of (i), (ii), (iii) and (iv) for the preparation of a medicament for the treatment of neurodegenerative disease. |
| isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2008054498-A2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-0216430-A2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-9740070-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2008054498-A3
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-03103702-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-1313149-C
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-7951778-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-6239107-B1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-9947159-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-6713445-B1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/AU-715036-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/FR-2775902-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-8153599-B1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-0216430-A3 |
| priorityDate |
1993-03-16-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |